Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing regulatable gene expression using adenoviral vectors.

Youn-Bok Lee1, Colin P J Glover, A Siobhan Cosgrave

  • 1Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, UK.

Experimental Physiology
|November 16, 2004
PubMed
Summary

This study optimized the tetracycline (Tet) gene control system for inducible gene expression. By separating Tet components into distinct adenoviral vectors and adding a WPRE enhancer, researchers achieved tight, non-toxic transgene control, benefiting neuronal gene therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular profiling of brain endothelial cell to astrocyte endfoot communication in mouse and human.

Nature communications·2025
Same author

Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons.

Stem cell reports·2024
Same author

AZD5438 a GSK-3a/b and CDK inhibitor is antiapoptotic modulates mitochondrial activity and protects human neurons from mitochondrial toxins.

Scientific reports·2023
Same author

Interactome screening of C9orf72 dipeptide repeats reveals VCP sequestration and functional impairment by polyGA.

Brain : a journal of neurology·2021
Same author

Cytoplasmic TDP-43 is involved in cell fate during stress recovery.

Human molecular genetics·2021
Same author

Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue.

ACS applied materials & interfaces·2021

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Neuroscience

Background:

  • Inducible gene expression systems often face challenges like inducer toxicity, basal expression (leakiness), and low expression levels.
  • The tetracycline (Tet) gene control system is a prominent example of a tightly regulated system for controlling transgene expression.
  • Optimizing these systems is crucial for advancing gene therapy and understanding gene function.

Purpose of the Study:

  • To enhance the efficacy and safety of the Tet gene control system for inducible transgene expression.
  • To investigate the optimal configuration of Tet system components within adenoviral vectors.
  • To assess the impact of the Woodchuck hepatitis virus post-transcriptional enhancer (WPRE) on Tet-regulatable adenoviral systems.

Main Methods:

Related Experiment Videos

  • Separating Tet transactivators and tetracycline responsive element (TRE) components into distinct adenoviral vectors.
  • Incorporating the Woodchuck hepatitis virus post-transcriptional enhancer (WPRE) into the dual vector system.
  • Evaluating transgene expression levels, regulation, and inflammatory responses at low adenoviral vector titres.

Main Results:

  • Individual Tet system components function optimally when delivered via separate adenoviral vectors.
  • The addition of WPRE enabled the dual vector Tet-regulatable Ad system to function effectively at very low titres (2 x 10^4).
  • The optimized system demonstrated minimal inflammatory response without compromising transgene expression or regulatory control.

Conclusions:

  • This optimized dual vector Tet-regulatable adenoviral system offers non-toxic and tightly controlled transgene expression.
  • The system's efficiency at low titres and minimal inflammatory response make it highly suitable for neuronal gene function studies.
  • This advancement holds significant promise for developing effective neuronal gene therapy strategies.